Review25-Hydroxyvitamin D assays: Potential interference from other circulating vitamin D metabolites
Introduction
The vitamin D External Quality Assessment Scheme (DEQAS) is an international external quality assessment scheme which has been assessing the performance of 25-hydroxyvitamin D (25-OHD) assays since 1989 and 1,25-dihydroxyvitamin D (1,25(OH)2D) assays since 1997. The scheme was extended in April 2015 to cover 24,25-dihydroxyvitamin D (24,25(OH)2D). Performance assessment is achieved by the quarterly distribution of 5 samples of human serum to the approximately 1100 laboratories participating in the 25-OHD scheme. DEQAS has participants in 53 countries (October 2014). Samples are prepared from blood donated locally by polycythaemic or haemochromatosis patients undergoing therapeutic venesection and, since April 2013, from serum purchased from the USA (Solomon Park, Kirkland, WA, USA).
Since April 2013, as a result of support from the NIH Office of Dietary Supplements, the 25-OHD scheme has been accuracy based with values assigned to each sample by the NIST reference measurement procedure (RMP) [1]. Thus DEQAS is well placed to assess the accuracy (bias) and specificity of 25-OHD methods in a routine laboratory setting.
The vitamin D metabolite 24,25(OH)2D, concentrations of which can range from 2% to 20% of total 25-OHD [2], is known to cross react in several ligand binding assays and might account for their variable bias, particularly in samples with high 25-OHD. Many routine HPLC/UV and LC–MS/MS assays fail to resolve 3-epi-25-OHD3 from 25-OHD3 which might contribute to the persistent positive bias seen in these methods [3].
The objectives of this study were twofold:
- 1.
To measure the concentration of 3-epi-25-OHD3 and 24R,25(OH)2D3 in a series of DEQAS samples and determine the relationship of each metabolite to 25-OHD3.
- 2.
To calculate the cross reactivity of 24R,25(OH)2D3 and 24S,25(OH)2D3 in commonly used ligand binding assays for 25-OHD and the degree of interference in HPLC/UV and LC–MS/MS methods.
Section snippets
Assignment of values to DEQAS samples
The concentrations of 25-OHD3 and 25-OHD2 were determined by NIST using their LC–MS/MS reference measurement procedure (RMP) [1]. A non-RMP, but similar method was employed for 3-epi-25OHD3 determination. The concentrations of 24,25(OH)2D3 were determined by LC–MS/MS using the method of Kaufmann et al. [4].
Spiking of pools with 3-epi-25-OHD3, 24S,25(OH)2D3 and 24R,25(OH)2D3
Synthetic vitamin D metabolites: 3-epi-25-OHD3, 24S,25(OH)2D3 and 24R,25(OH)2D3 were obtained from Sigma–Aldrich (Gillingham, Dorset, UK) and used without further purification. The
Results
3-epi-25-OHD3 and 24,25(OH)2D3 both showed strong positive correlations with 25-OHD3 (Fig. 1, Fig. 2) with the regression lines crossing the 25-OHD axis at approximately 20 and 15 nmol/L respectively.
The Roche total 25-OHD competitive protein binding assay showed a cross reactivity* of 56% with 3-epi-25-OHD3 but no significant interference was observed in any of the immunoassays. In general, HPLC/UV and LC–MS/MS methods did not resolve the 3-epimer from 25-OHD3 (Fig. 3).
In samples spiked with
Discussion
3-epi-25-OHD3 can be present in very high concentrations in neonates of up to one year of age(≈50% of 25-OHD3) and the metabolite is now known to be present in most adult sera [5], [6], [7]. In a study of 216 random clinical samples (211 from patients >20 years of age), mean (SD) 3-epi-25-OHD3 concentration was 3.8 (4.8) nmol/L (range 0.25–59.3 nmol/L); 92% of results were below 7.5 nmol/L [7]. Many routine HPLC/UV and LC–MS/MS assays fail to resolve the 3-epimer from 25-OHD3 in the chromatography
Acknowledgements
We are grateful to our NIST colleagues Carolyn Burdette, Johanna Camara, Lane Sander, Susan Tai and Stephen Wise for the provision of 25-OHD target values, without which DEQAS could not function as an accuracy based quality assessment scheme.
Our thanks to the patients and staff of the Haematology Clinic at Hammersmith Hospital for their invaluable assistance in providing blood donations.
References (10)
- et al.
Variability in the analysis of 25-hydroxyvitamin D by liquid chromatography–tandem mass spectrometry: the devil is in the detail
Clin. Chim. Acta
(2012) - et al.
3-epi-25 hydroxyvitamin D concentrations are not correlated with age in a cohort of infants and adult
Clin. Chim. Acta.
(2012) - et al.
The anomalous behaviour of exogenous 25-hydroxyvitamin D in competitive binding assays
J. Steroid Biochem. Mol. Biol.
(2007) - et al.
Development of a candidate reference measurement procedure for the determination of 25-hydroxyvitamin D3 and 25-hydroxyvitamin D2 in human serum using isotope-dilution liquid chromatography–tandem mass spectrometry
Anal. Chem.
(2010) - et al.
Significance of serum 24,25-dihydroxyvitamin D in the assessment of vitamin D status: a double-edged sword?
Clin. Chem.
(2015)